Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Feb 2025 for Revance Therapeutics, Inc., €59k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Carey OConnor Kolaja: trading record in brief
Carey OConnor Kolaja is a declared insider of Revance Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 6 filings, for trades running from 5 May 2021 to 4 February 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 6 February 2025 with a transaction (€59k) in Revance Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Carey OConnor Kolaja
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
16,561 shares@ US$3.6558.6% of flowCommon StockSEC:0000950170-25-015353:0
15,000 shares0Common StockSEC:0001479290-24-000087:0
2,500 shares@ US$18.1241.4% of flowCommon StockSEC:0001479290-23-000080:0
3,534 shares0Common StockSEC:0001479290-23-000061:0
6,059 shares0Common StockSEC:0001479290-22-000062:0
674 shares0Common StockSEC:0001479290-21-000110:0
6 of 6 declarations
